View Past PerformanceNeurones バランスシートの健全性財務の健全性 基準チェック /56Neuronesの総株主資本は€464.9M 、総負債は€14.1Mで、負債比率は3%となります。総資産と総負債はそれぞれ€749.0Mと€284.2Mです。 Neuronesの EBIT は€75.6Mで、利息カバレッジ比率-8.3です。現金および短期投資は€340.8Mです。主要情報3.03%負債資本比率€14.07m負債インタレスト・カバレッジ・レシオ-8.3x現金€340.78mエクイティ€464.87m負債合計€284.16m総資産€749.03m財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesDeclared Dividend • May 20Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.7%, which is higher than the industry average of 2.1%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre FranceBoard Change • Dec 30Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre Franceお知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.Buy Or Sell Opportunity • Apr 26Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €44.80. The fair value is estimated to be €56.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Buy Or Sell Opportunity • Apr 11Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 9.5% to €46.60. The fair value is estimated to be €38.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.Board Change • Mar 26Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 28Neurones S.A. to Report First Half, 2024 Results on Sep 11, 2024Neurones S.A. announced that they will report first half, 2024 results on Sep 11, 2024財務状況分析短期負債: NE9の 短期資産 ( €608.5M ) が 短期負債 ( €250.1M ) を超えています。長期負債: NE9の短期資産 ( €608.5M ) が 長期負債 ( €34.1M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: NE9総負債よりも多くの現金を保有しています。負債の削減: NE9の負債対資本比率は、過去 5 年間で0.2%から3%に増加しました。債務返済能力: NE9の負債は 営業キャッシュフロー によって 十分にカバー されています ( 506.6% )。インタレストカバレッジ: NE9支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YSoftware 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 07:54終値2026/05/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Neurones S.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Alexandre PlaudCIC Market Solutions (ESN)
Declared Dividend • May 20Dividend increased to €1.40Dividend of €1.40 is 7.7% higher than last year. Ex-date: 10th June 2026 Payment date: 12th June 2026 Dividend yield will be 3.7%, which is higher than the industry average of 2.1%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased by an average of 37% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 28Neurones S.A., Annual General Meeting, Jun 04, 2026Neurones S.A., Annual General Meeting, Jun 04, 2026. Location: 205 avenue georges clemenceau, nanterre France
Board Change • Dec 30Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. No experienced directors. 6 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 08Neurones S.A. Provides Earnings Guidance for the Full Year 2025Neurones S.A. provided earnings guidance for the full year 2025. For the year, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% .
お知らせ • Nov 05Neurones S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Neurones S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
お知らせ • Apr 29Neurones S.A., Annual General Meeting, Jun 05, 2025Neurones S.A., Annual General Meeting, Jun 05, 2025. Location: 205 avenue georges clemenceau, nanterre France
お知らせ • Mar 06Neurones S.A. Proposes Dividend for 2024Neurones S.A. announced that att the Shareholders' Meeting on June 5, 2025, the Board will suggest paying a dividend of €1.3 per share for 2024 (compared with €1.2 the previous year).
お知らせ • Sep 19+ 1 more updateNeurones S.A. to Report First Half, 2025 Results on Sep 10, 2025Neurones S.A. announced that they will report first half, 2025 results on Sep 10, 2025
お知らせ • May 17Neurones S.A. Provides Earnings Guidance for the Year 2024Neurones S.A. provided earnings guidance for the year 2024. For the period, the company forecasts close to €800 million in revenues, operating profit of around 9.5%.
Buy Or Sell Opportunity • Apr 26Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €44.80. The fair value is estimated to be €56.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Buy Or Sell Opportunity • Apr 11Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 9.5% to €46.60. The fair value is estimated to be €38.61, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue is forecast to grow by 7.0% in a year. Earnings are forecast to grow by 10% in the next year.
Board Change • Mar 26Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Marie-Françoise Jaubert was the last independent director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 28Neurones S.A. to Report First Half, 2024 Results on Sep 11, 2024Neurones S.A. announced that they will report first half, 2024 results on Sep 11, 2024